1-12 of 12
Olufunmilayo I. Olopade
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The VEGF-Hypoxia Signature Is Upregulated in Basal-like Breast Tumors from Women of African Ancestry and Associated with Poor Outcomes in Breast Cancer

Yoo Jane Han, Siyao Liu, Ashley Hardeman, Padma Sheila Rajagopal, Jeffrey Mueller, Galina Khramtsova, Ayodele Sanni, Mustapha Ajani, Wendy Clayton, Ian W. Hurley, Toshio F. Yoshimatsu, Yonglan Zheng, Joel Parker, Charles M. Perou, Olufunmilayo I. Olopade
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (11): 2609–2618.
https://doi.org/10.1158/1078-0432.CCR-23-1526
Published: 03 June 2024
View article titled, The VEGF-Hypoxia Signature Is Upregulated in Basal-like Breast Tumors from Women of African Ancestry and Associated with Poor Outcomes in Breast Cancer
Open the PDF for The VEGF-Hypoxia Signature Is Upregulated in Basal-like Breast Tumors from Women of African Ancestry and Associated with Poor Outcomes in Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Intensive Surveillance with Biannual Dynamic Contrast-Enhanced Magnetic Resonance Imaging Downstages Breast Cancer in BRCA1 Mutation Carriers

Rodrigo Santa Cruz Guindalini, Yonglan Zheng, Hiroyuki Abe, Kristen Whitaker, Toshio F. Yoshimatsu, Tom Walsh, David Schacht, Kirti Kulkarni, Deepa Sheth, Marion S. Verp, Angela R. Bradbury, Jane Churpek, Elias Obeid, Jeffrey Mueller, Galina Khramtsova, Fang Liu, Akila Raoul, Hongyuan Cao, Iris L. Romero, Susan Hong, Robert Livingston, Nora Jaskowiak, Xiaoming Wang, Marcio Debiasi, Colin C. Pritchard, Mary-Claire King, Gregory Karczmar, Gillian M. Newstead, Dezheng Huo, Olufunmilayo I. Olopade
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2019) 25 (6): 1786–1794.
https://doi.org/10.1158/1078-0432.CCR-18-0200
Published: 15 March 2019
View article titled, Intensive Surveillance with Biannual Dynamic Contrast-Enhanced Magnetic Resonance Imaging Downstages Breast Cancer in <em>BRCA1</em> Mutation Carriers
Open the PDF for Intensive Surveillance with Biannual Dynamic Contrast-Enhanced Magnetic Resonance Imaging Downstages Breast Cancer in <em>BRCA1</em> Mutation Carriers in another window
Includes: Supplementary data
Journal Articles

The Neoadjuvant Model Is Still the Future for Drug Development in Breast Cancer

Angela DeMichele, Douglas Yee, Donald A. Berry, Kathy S. Albain, Christopher C. Benz, Judy Boughey, Meredith Buxton, Stephen K. Chia, Amy J. Chien, Stephen Y. Chui, Amy Clark, Kirsten Edmiston, Anthony D. Elias, Andres Forero-Torres, Tufia C. Haddad, Barbara Haley, Paul Haluska, Nola M. Hylton, Claudine Isaacs, Henry Kaplan, Larissa Korde, Brian Leyland-Jones, Minetta C. Liu, Michelle Melisko, Susan E. Minton, Stacy L. Moulder, Rita Nanda, Olufunmilayo I. Olopade, Melissa Paoloni, John W. Park, Barbara A. Parker, Jane Perlmutter, Emanuel F. Petricoin, Hope Rugo, Fraser Symmans, Debasish Tripathy, Laura J. van‘t Veer, Rebecca K. Viscusi, Anne Wallace, Denise Wolf, Christina Yau, Laura J. Esserman
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (13): 2911–2915.
https://doi.org/10.1158/1078-0432.CCR-14-1760
Published: 30 June 2015
View article titled, The Neoadjuvant Model Is Still the Future for Drug Development in Breast Cancer
Open the PDF for The Neoadjuvant Model Is Still the Future for Drug Development in Breast Cancer in another window
Journal Articles

Hidden Dangers: A Cryptic Exon Disrupts BRCA2 mRNA

James D. Fackenthal, Younghee Lee, Olufunmilayo I. Olopade
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (18): 4865–4867.
https://doi.org/10.1158/1078-0432.CCR-12-2090
Published: 16 September 2012
View article titled, Hidden Dangers: A Cryptic Exon Disrupts <em>BRCA2</em> mRNA
Open the PDF for Hidden Dangers: A Cryptic Exon Disrupts <em>BRCA2</em> mRNA in another window
Includes: Supplementary data
Journal Articles

Molecular Analysis of Colorectal Tumors within a Diverse Patient Cohort at a Single Institution

Brooke E. Sylvester, Dezheng Huo, Andrey Khramtsov, Jing Zhang, Rana V. Smalling, Sope Olugbile, Blase N. Polite, Olufunmilayo I. Olopade
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (2): 350–359.
https://doi.org/10.1158/1078-0432.CCR-11-1397
Published: 16 January 2012
View article titled, Molecular Analysis of Colorectal Tumors within a Diverse Patient Cohort at a Single Institution
Open the PDF for Molecular Analysis of Colorectal Tumors within a Diverse Patient Cohort at a Single Institution in another window
Includes: Supplementary data
Journal Articles

Advances in Breast Cancer: Pathways to Personalized Medicine

Olufunmilayo I. Olopade, Tatyana A. Grushko, Rita Nanda, Dezheng Huo
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (24): 7988–7999.
https://doi.org/10.1158/1078-0432.CCR-08-1211
Published: 15 December 2008
View article titled, Advances in Breast Cancer: Pathways to Personalized Medicine
Open the PDF for Advances in Breast Cancer: Pathways to Personalized Medicine in another window
Journal Articles

Estrogen Receptor Status in BRCA1 - and BRCA2 -Related Breast Cancer: The Influence of Age, Grade, and Histological Type

William D. Foulkes, Kelly Metcalfe, Ping Sun, Wedad M. Hanna, Henry T. Lynch, Parviz Ghadirian, Nadine Tung, Olufunmilayo I. Olopade, Barbara L. Weber, Jane McLennan, Ivo A. Olivotto, Louis R. Bégin, Steven A. Narod
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (6): 2029–2034.
https://doi.org/10.1158/1078-0432.CCR-03-1061
Published: 24 March 2004
View article titled, Estrogen Receptor Status in <em>BRCA1</em> - and <em>BRCA2</em> -Related Breast Cancer: <subtitle>The Influence of Age, Grade, and Histological Type</subtitle>
Open the PDF for Estrogen Receptor Status in <em>BRCA1</em> - and <em>BRCA2</em> -Related Breast Cancer: <subtitle>The Influence of Age, Grade, and Histological Type</subtitle> in another window
Journal Articles

MYC Is Amplified in BRCA1 -Associated Breast Cancers

Tatyana A. Grushko, James J. Dignam, Soma Das, Anne M. Blackwood, Charles M. Perou, Karin K. Ridderstråle, Kristin N. Anderson, Min-Jie Wei, April J. Adams, Fitsum G. Hagos, Lise Sveen, Henry T. Lynch, Barbara L. Weber, Olufunmilayo I. Olopade
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (2): 499–507.
https://doi.org/10.1158/1078-0432.CCR-0976-03
Published: 03 February 2004
View article titled, <em>MYC</em> Is Amplified in <em>BRCA1</em> -Associated Breast Cancers
Open the PDF for <em>MYC</em> Is Amplified in <em>BRCA1</em> -Associated Breast Cancers in another window
Journal Articles

Alterations of the 9p21 and 9q33 Chromosomal Bands in Clinical Bladder Cancer Specimens by Fluorescence in Situ Hybridization

Walter M. Stadler, Gary Steinberg, Ximing Yang, Fitsum Hagos, Craig Turner, Olufunmilayo I. Olopade
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (6): 1676–1682.
Published: 01 June 2001
View article titled, Alterations of the 9p21 and 9q33 Chromosomal Bands in Clinical Bladder Cancer Specimens by Fluorescence <em>in Situ</em> Hybridization
Open the PDF for Alterations of the 9p21 and 9q33 Chromosomal Bands in Clinical Bladder Cancer Specimens by Fluorescence <em>in Situ</em> Hybridization in another window
Journal Articles

Chronic Daily Low Dose of 4-Methyl-5-(2-pyrazinyl)-1,2-dithiole-3-thione (Oltipraz) in Patients with Previously Resected Colon Polyps and First-Degree Female Relatives of Breast Cancer Patients

Al B. Benson, III, Olufunmilayo I. Olopade, Mark J. Ratain, Alfred Rademaker, Sohrab Mobarhan, Lisa Stucky-Marshall, Suzanne French, M. Eileen Dolan
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (10): 3870–3877.
Published: 01 October 2000
View article titled, Chronic Daily Low Dose of 4-Methyl-5-(2-pyrazinyl)-1,2-dithiole-3-thione (Oltipraz) in Patients with Previously Resected Colon Polyps and First-Degree Female Relatives of Breast Cancer Patients
Open the PDF for Chronic Daily Low Dose of 4-Methyl-5-(2-pyrazinyl)-1,2-dithiole-3-thione (Oltipraz) in Patients with Previously Resected Colon Polyps and First-Degree Female Relatives of Breast Cancer Patients in another window
Journal Articles

Human Breast Cancer Susceptibility to Paclitaxel Therapy Is Independent of Bcl-2 Expression

Susan M. Poelman, Moses O. Adeyanju, Maria-Antonia Robertson, Wendy M. Recant, Theodore Karrison, Gini F. Fleming, Olufunmilayo I. Olopade, Suzanne D. Conzen
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (10): 4043–4048.
Published: 01 October 2000
View article titled, Human Breast Cancer Susceptibility to Paclitaxel Therapy Is Independent of Bcl-2 Expression
Open the PDF for Human Breast Cancer Susceptibility to Paclitaxel Therapy Is Independent of Bcl-2 Expression in another window
Journal Articles

Lack of Evidence for a Polymorphism at Codon 160 of Human O6-Alkylguanine-DNA Alkyltransferase Gene in Normal Tissue and Cancer

Michael H. Wu, Karen E. Lohrbach, Olufunmilayo I. Olopade, Demetrius M. Kokkinakis, Henry S. Friedman, M. Eileen Dolan
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (1): 209–213.
Published: 01 January 1999
View article titled, Lack of Evidence for a Polymorphism at Codon 160 of Human <em>O</em><sup>6</sup>-Alkylguanine-DNA Alkyltransferase Gene in Normal Tissue and Cancer
Open the PDF for Lack of Evidence for a Polymorphism at Codon 160 of Human <em>O</em><sup>6</sup>-Alkylguanine-DNA Alkyltransferase Gene in Normal Tissue and Cancer in another window